Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

7.80
Delayed Data
As of May 02
 +0.06 / +0.78%
Today’s Change
5.21
Today|||52-Week Range
30.13
-22.47%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close7.74
Today’s open7.91
Day’s range7.41 - 7.92
Volume608,936
Average volume (3 months)948,739
Market cap$263.9M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-13.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.12+1.75%
VTLVital Therapies Inc-0.13-1.52%
VSARVersartis Inc+0.04+0.44%
ITEKInotek Pharmaceutica...+0.55+5.61%
Data as of 05/02/2016

Financials

Next reporting dateJune 13, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, Director &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs